Status:

RECRUITING

Coagulopathy of Immunodermatologic Diseases

Lead Sponsor:

University of Nebraska

Conditions:

Autoimmune Bullous Dermatosis

Eligibility:

All Genders

19+ years

Brief Summary

This study will examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases. Blood samples will be collected from participants with active/poorly controlled immune-mediate...

Detailed Description

The purpose of this study is to examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases. This will be accomplished by collecting blood samples from participants with b...

Eligibility Criteria

Inclusion

  • For the study group: diagnosis of immune-mediated skin disease including but not limited to bullous pemphigoid, pemphigus vulgaris, mucous membrane pemphigoid, cutaneous lupus erythematosus, dermatomyositis
  • For control group: no diagnosis of immune-mediated skin
  • For study group: receiving care from one or more of the Principal or Secondary Investigators

Exclusion

  • Unfit to provide consent
  • P2Y12 inhibitor use in the past 4 weeks
  • History of internal malignancy prior to enrolling in the study or suspected internal/systemic malignancy during time of the study (i.e. will not exclude pre-malignant or local, early stage cutaneous malignancies)
  • Major surgery within 4 weeks of the study or trauma (e.g., accident-causing bone fracture) within 4 weeks of the study
  • Other autoimmune diseases not in remission defined as flare in the last 12 weeks
  • If patient is unable to provide detailed history and if we do not have sufficient history on record.
  • Less than 19 years of age

Key Trial Info

Start Date :

May 9 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT06037187

Start Date

May 9 2023

End Date

December 1 2025

Last Update

August 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Nebraska Medical Center

Omaha, Nebraska, United States, 68198

Coagulopathy of Immunodermatologic Diseases | DecenTrialz